Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

P5367

Sigma-Aldrich

Anti-Par-4 (Prostate Apoptosis Response-4) antibody produced in rabbit

IgG fraction of antiserum, buffered aqueous solution

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Numéro MDL:
Code UNSPSC :
12352203
Nomenclature NACRES :
NA.46

Source biologique

rabbit

Niveau de qualité

Conjugué

unconjugated

Forme d'anticorps

IgG fraction of antiserum

Type de produit anticorps

primary antibodies

Clone

polyclonal

Forme

buffered aqueous solution

Poids mol.

antigen 38 kDa

Espèces réactives

human, rat, mouse

Technique(s)

microarray: suitable
western blot: 1:1,000 using whole cell extract of the mouse fibroblast NIH3T3 cell line
western blot: 1:5,000 using whole cell extract of the human HeLa cell line

Numéro d'accès UniProt

Conditions d'expédition

dry ice

Température de stockage

−20°C

Modification post-traductionnelle de la cible

unmodified

Informations sur le gène

human ... PAWR(5074)
mouse ... Pawr(114774)
rat ... Pawr(64513)

Description générale

PRKC apoptosis WT1 regulator protein (PAWR) is also known as prostate apoptosis response 4 protein (Par-4). The PAWR gene is mapped to human chromosome 12q21.2. It is a 40 kDa protein expressed ubiquitously in mammals. It was first identified in prostate tumors.It has a leucine zipper domain and nuclear localization sequences. A core domain comprising of region 137-195 amino acids is critical for the apoptotic function of PAR-4. It interacts and modulates the activity of protein kinase C.

Immunogène

synthetic peptide corresponding to the C-terminus of human Par-4 (amino acids 324-342) conjugated to KLH.

Application

Anti-Par-4 (Prostate Apoptosis Response-4) antibody produced in rabbit may be used in immunoblotting.

Actions biochimiques/physiologiques

Par-4 protein interacts with Wilm′s tumor suppressor WT1 and modulates its transcription and growth suppression function. The gene for Par-4 is down-regulated by oncogenic Ras via the Raf-1- mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK-ERK) pathway in immortalized fibroblasts. Overexpression of the PAR4 gene causes down-regulation of B-cell lymphoma-2 (Bcl-2) in fibroblasts and prostate cancer cells. Par-4 protein plays an important role in neuronal apoptosis. This gene is upregulated in neuronal degeneration and is observed in Alzheimer′s disease.
The primary function of prostate apoptosis response 4 protein (Par-4) is to mediate apoptosis. In neuronal progenitor cells, ceramide and PAR-4 contribute to rapid apoptosis. PAR-4 activates the tumor necrosis factor receptor superfamily member (FAS)-based death signalling caspase cascade to accomplish apoptosis in prostate tumor cells. PAR-4 is considered as a potential drug for treatment of cancer and neurodegenerative disorders.

Forme physique

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Stockage et stabilité

For continuous use, store at 2-8 °C for up to one month.For prolonged storage, freeze in working aliquots at −20 °C. Repeated freezing and thawing is not recom-mended. Storage in frost-free freezers is also notrecommended. If slight turbidity occurs upon prolongedstorage, clarify the solution by centrifugation beforeuse. Working dilutions should be discarded if not usedwithin 12 hours.

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Vous ne trouvez pas le bon produit ?  

Essayez notre Outil de sélection de produits.


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Apoptosis by Par-4 in cancer and neurodegenerative diseases
El-Guendy N and Rangnekar VM
Experimental Cell Research, 283(1), 51-66 (2003)
Nikhil Hebbar et al.
Cancer research, 77(15), 4039-4050 (2017-06-20)
Primary tumors are often heterogeneous, composed of therapy-sensitive and emerging therapy-resistant cancer cells. Interestingly, treatment of therapy-sensitive tumors in heterogeneous tumor microenvironments results in apoptosis of therapy-resistant tumors. In this study, we identify a prostate apoptosis response-4 (Par-4) amino-terminal fragment
PAWR (PRKC apoptosis WT1 regulator protein; Prostate apoptosis response-4, Par-4
Shukla N, et al.
Atlas of Genetics and Cytogenetics in Oncology and Haematology (2016)
R W Johnstone et al.
Molecular and cellular biology, 16(12), 6945-6956 (1996-12-01)
The tumor suppressor WT1 represses and activates transcription. The loss and/or imbalance of the dual transcriptional activity of WT1 may contribute to Wilms' tumor. In this study, we identified par-4 (for prostate apoptosis response) as a WT1-interacting protein that itself
Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramide
Bieberich E, et al.
The Journal of Cell Biology, 162(3), 469-479 (2003)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique